ANTIPARKINSON DRUGS AS CAUSAL AGENTS IN TARDIVE DYSKINESIA
- 1 September 1973
- journal article
- Published by AMPCo in The Medical Journal of Australia
- Vol. 2 (12), 591-593
- https://doi.org/10.5694/j.1326-5377.1973.tb129673.x
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- LEVODOPA IN PARKINSON'S DISEASE—AUSTRALIAN COLLABORATIVE TRIALThe Medical Journal of Australia, 1973
- Therapeutic Approaches to Tardive DyskinesiaArchives of General Psychiatry, 1972
- THEORETICAL IMPLICATIONS OF THE USE OF L-DOPA IN PARKINSONISM.Acta Neurologica Scandinavica, 1970
- The bucco-linguo-masticatory syndrome as a side-effect of neuroleptics therapyPsychiatric Quarterly, 1967
- Persistent Dyskinesias Following Phenothiazine TherapyArchives of Neurology, 1966
- Toxicity of Psychotropic DrugsProceedings of the Royal Society of Medicine, 1964
- DISCONTINUATION OF MAINTENANCE DOSAGES OF ATARACTIC DRUGS ON A PSYCHIATRIC CONTINUED TREATMENT WARDJournal of Nervous & Mental Disease, 1962